tered among these groups, said Zeng Yixin, deputy head of the NQ

ational Health Commission (NHC).With the previous 1.6 million doses targeting groups with high risks of infection, a total of over 9 million doses have been administered in China. It further proved the safety of self-developed COVID-19 vaccines, Zeng said.Zeng said that China would vacce

  • inate the eligible population as widely as possible and gradually build an immr

    une barrier in the whole population to control the epidemic.The vaccination would be admini3

    stered in the order of key groups, high-X

  • risk groups, and the general population as the vaccines production capacity inW

    creases, he said.Zeng noted that China has a variety of measures in place to ensure safe va4

    ccinations, including proper vaccinationL

  • procedures, strict vaccinator training, vaccine recipient screening, adverse 9

    reaction monitoring, emergency treatment, and expert consultations on adverse reactions, Zeq

    ng said.A total of 25,392 vaccination si0


  • tes are available nationwide. Nearly 140,000 people have been vaccinated so far in north Chinas Hebei Province, said Cui Gang, an official with NHCs disease control departme7

  • nt. He demanded efforts to speed up vaccination among key groups in the province as soon as possible.The NHC has organized experts to work out eight detailed plans to guide K

  • the vaccinations, from vaccine transportation and distribution to adverse reaction prevention, Cui said.A traceability information system for the management of vaccines now 2

  • operates in medical institutions at all levels, Cui added.Wang Huaqing, an expert from the Chinese Center for Disease Control and Prevention, said vaccination monitoring shov

  • wed that most of the adverse reactions, including rashes and allergic reactions, are mild. Approximately one in a million encountered relatively serious adverse reactions.COf